Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-24, Stock:NVO, The news for the past five days is as follows:
2019-06-17: NEWS1: FDA approves non-insulin Type 2 diabetes drug for kids, the first to hit market in 20 years.
2019-06-18: NEWS1: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS2: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS3: Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients.NEWS4: The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale.NEWS5: Shares of cancer-therapy companies skyrocket after Pfizer acquisition news.
2019-06-19: NEWS1: NVS or NVO: Which Is the Better Value Stock Right Now?.NEWS2: NVS or NVO: Which Is the Better Value Stock Right Now?.NEWS3: NVS or NVO: Which Is the Better Value Stock Right Now?.
2019-06-20: NEWS1: Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs.NEWS2: Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs.NEWS3: Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs.
2019-06-21: NEWS1: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS2: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS3: Novo Nordisk's Haemophilia A Drug Esperoct Gets EU Approval.NEWS4: Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod.NEWS5: Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod.NEWS6: Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod.

Answer: Rise